The global AI in drug discovery and development market was valued at US$6.24 billion in 2024 and is forecast to grow at an 18.5% CAGR, reaching US$34.05 billion by 2033, driven by AI’s ability to accelerate target identification, optimize lead compounds, and streamline clinical trials through advanced machine learning and data analytics https://www.datamintelligence.com/research-report/ai-in-drug-discovery-and-development-market